Manufacturer of the antipsychotic drug Risperdal (risperidone), Johnson & Johnson, is facing a growing number of allegations that young boys throughout the United States have developed male breast tissue because of the medication. Studies show that side effects of Risperdal may cause a condition known as gynecomastia, the abnormal breast growth or enlargement among male young adults and children. Studies have also shown that Risperdal may raise the levels of prolactin, a protein hormone which stimulates the development of breast in women, thus responsible for the development of enlarged breasts and even milk production in boys who are taking this powerful antipsychotic medication.
In 1993, Risperdal was approved by the FDA for the short-term treatment of adults diagnosed with schizophrenia. In 2003, the medication was also approved to cure extreme mood swings associated with acute manic or mixed episodes. Following this in 2006 and 2007, Risperdal was approved for pediatric uses which include short-term treatment of bipolar disorders as well as irritability associated with autism. Gynecomastia can be severe with reported cup-sizes up to 38D. Risperdal is also known to cause tremendous weight gain which can worsen gynecomastia with fat deposits (adipose tissue) in the breast. Although breast growth caused by Risperdal is non-cancerous, young boys and teenagers may feel extremely humiliated with their appearance. They are prone to teasing along with other serious long-term psychological consequences that can lead to a devastating impact on their overall quality of mental health and life such as social problems, depression and low self-esteem.
Most common Risperdal side effects include:
- Gynecomastia (male breast growth)
- Medically serious weight gain
- Neuroleptic Malignant Syndrome
- Delayed onset of puberty
- Sexual dysfunction and Infertility
- Type 2 diabetes and Blood-sugar disorders
- Heart attack and Irregular heart rhythm
- Bone loss and Poor growth
To lower the risk of emotional and physical problems, most doctors recommend surgical treatment of gynecomastia. Since this procedure can result in distorted breasts, liposuction and additional procedures may be needed to improve the appearance of the breast. Allegations claim that the manufacturer failed to adequately warn both the patients and the medical community regarding the risk of Risperdal’s side effects. These plaintiffs also allege the manufacturer of illegal off-label marketing of their product even before the FDA approved the drug for use among children. If you or anyone you know suffered from gynecomastia caused by Risperdal, , Please Contact Us and provide any details along with contact information. If you prefer to leave a voicemail you can call 1.858.236.9020. GetClassActionMoney.com can then forward these requests to our network of attorneys that may contact you if a Class Action Lawsuit is to be pursued.
In addition make sure you Subscribe to our mailing list to receive important updates regarding class action news and open cases.